Management of non-resectable (Stage III) breast cancer

Conference · Sat Sep 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

OSTI ID:5333033

Sponzo, R W ^[1]; Cunningham, T J; Caradonna, R R; Antemann, R

---

1. Albany Regional Cancer Center, NY

Thirteen patients with stage T3b or T4 breast carcinoma were treated with radiation and chemotherapy. The radiation therapy (RT) was given to the involved breast and adjacent nodal areas to a dose of 7000 to 9000 rad over 8 to 10 weeks. The chemotherapy consisted of cyclophosphamide 150 mg/m/sup 2/ and 5FU 300 mg/m/sup 2/ IV days 1 to 5 repeated every 5 weeks and Prednisone 10 mg PO qd (CFP). All patients received 12 cycles of chemotherapy - 6 patients began CFP within one month of completion of RT and 6 received CFP and RT simultaneously. Characteristics of the patients were: mean age 57, menopausal status - 4 pre and 8 post with a mean years post-menopausal of 10. All patients had only evidence of localized disease. Eleven of the 13 patients remain in complete remission with a median duration of complete response of 38+ months. One patient receiving simultaneous CFP and RT relapsed after completion of RT. One patient receiving simultaneous CFP and RT relapsed 2 months after completion of CFP. Local skin toxicity from radiation was significantly greater in those receiving simultaneous CFP and RT. The role of radiation therapy combined with chemotherapy in the management of Stage III breast carcinoma is suggested and this will be explored further in an ECOG cooperative group trial.

• OSTI ID: 5333033
• Journal Information: Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 5:9; Conference: Conference on combined modalities: chemotherapy/radiotherapy. Part 2, Hilton Head Island, SC, USA, 15 Nov 1978
• Country of Publication: United States
• Language: English

Related Subjects

63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
62 RADIOLOGY AND NUCLEAR MEDICINE
CARCINOMAS
BIOLOGICAL RADIATION EFFECTS
ENDOXAN
RADIOSENSITIVITY EFFECTS
FLUOROURACILS
MAMMARY GLANDS
PATIENTS
RADIOTHERAPY
SIDE EFFECTS
SKIN
FRACTIONATED IRRADIATION
PREDNISONE
ADRENAL HORMONES
ALKYLATING AGENTS
ANTIMETABOLITES
ANTIMITOTIC DRUGS
AZINES
BIOLOGICAL EFFECTS
BODY
CORTICOSTEROIDS
DISEASES
DRUGS
GLANDS
GLUCOCORTICOIDS
HETEROCYCLIC COMPOUNDS
HORMONES
HYDROXY COMPOUNDS
IRRADIATION
KETONES
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC FLUORINE COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PREGNANES
PYRIMIDINES
RADIATION EFFECTS
RADIOLOGY
STEROID HORMONES
STEROIDS
THERAPY
URACILS
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)